title: TAH and BSO with adjuvant pelvic EXRT and vaginal Cs-137 boost in the management of carcinoma of the endometrium.
abstract: Combined surgery and radiation has become standard therapy for operable endometrial cancer patients with stage IA (grade 2-3 or deep muscle invasion), stage IB, stage II, and selected stage III disease. We discuss the rationale for whole pelvic external-beam radiation therapy (EXRT) followed by vaginal endocurietherapy (ECT) boost, and present the outcome of 43 patients with endometrial cancer treated by combined surgery and radiation.
authors.affiliation: Faculty of the Division of Radiation Oncology, Department of Radiology, University of Nebraska College of Medicine, Omaha.
authors.forename: P P
authors.initials: PP
authors.lastname: Kumar
authors.forename: R R
authors.initials: RR
authors.lastname: Good
authors.forename: J C
authors.initials: JC
authors.lastname: Scott
authors.forename: G F
authors.initials: GF
authors.lastname: McCaul
mesh_terms: D000230:Adenocarcinoma / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D001918:Brachytherapy; D002588:Cesium Radioisotopes / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D005187:Fallopian Tubes / Q000601:surgery*; D005260:Female; D006801:Humans; D007044:Hysterectomy; D010052:Ovariectomy; D011882:Radiotherapy, High-Energy; D014594:Uterine Neoplasms / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*
chemical_list: D002588:Cesium Radioisotopes